
CRISPR Therapeutics AG CRSP
€ 46.62
-3.73%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
CRISPR Therapeutics AG P/S 2011-2026 | CRSP
P/S Jährlich CRISPR Therapeutics AG
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.5 | 17.5 | 3.04 K | 6.29 | 14 K | 9.85 | 495 | 40.7 | 42.1 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14 K | 6.29 | 1.98 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 205.0 | -1.8 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.49 | 4.8 % | $ 8.4 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 1.08 | - | $ 5.89 M | ||
|
Adagene
ADAG
|
35.6 | $ 1.72 | 3.94 % | $ 96.8 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 63.65 | -2.08 % | $ 8.51 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Biogen
BIIB
|
2 | $ 188.59 | 1.39 % | $ 27.5 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.83 | -4.19 % | $ 467 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 2.0 | 0.01 % | $ 5.07 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.21 | -2.09 % | $ 9.16 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 10.66 | -2.87 % | $ 702 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 27.56 | 0.77 % | $ 1.77 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.41 | -1.56 % | $ 116 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 99.86 | 1.02 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 27.87 | 0.45 % | $ 1.35 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 11.4 | 0.48 % | $ 737 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
19.1 | $ 631.65 | 3.04 % | $ 47.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.66 | - | $ 16.7 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 94.98 | 1.03 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M |